⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
ARS PHARMACEUTICALS DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Pomerantz LLP Updates Investors on Legal Action Brought Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Join Class Action Before October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY
SPRY ALERT: Securities Fraud Class Action Launched Against ARS Pharmaceuticals, Inc. - October 5, 2026 Deadline
accessnewswire.com
SPRY
Class Action Lawsuit Filed: ARS Pharmaceuticals, Inc. (SPRY) - Join by October 5, 2026 - Contact Levi & Korsinsky
accessnewswire.com
SPRY
Kaplan Fox Announces a Securities Class Action Against ARS Pharmaceuticals Inc. (SPRY) - Lead Plaintiff Deadline is October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of ARS Pharmaceuticals Inc. to Contact the Firm Today!
accessnewswire.com
SPRY
October 5, 2026 Deadline Approaching: Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY) - Contact Levi & Korsinsky
accessnewswire.com
SPRY
SPRY Investor Alert: ARS Pharmaceuticals Inc. Securities Class Action Notice - Contact Levi & Korsinsky
prnewswire.com
SPRY
Kaplan Fox Reminds ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors with Significant Losses to Seek a Leadership Role Before Deadline on October 5, 2026
globenewswire.com
SPRY